// App-Quantinova.ai

PB1146 : Thrombin Generation Potential of Modified FIX: Dalcinonacog Alfa

Researchers

Presenter

  • S. Williams

Principal Investigators

  • E. Gray

Medical Centers

  • NIBSC, Biotherapeutics, Potters Bar, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

  • BeneFIX

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved